173 related articles for article (PubMed ID: 23346194)
1. Dose-Dependent Effects of the Cimicifuga racemosa Extract Ze 450 in the Treatment of Climacteric Complaints: A Randomized, Placebo-Controlled Study.
Schellenberg R; Saller R; Hess L; Melzer J; Zimmermann C; Drewe J; Zahner C
Evid Based Complement Alternat Med; 2012; 2012():260301. PubMed ID: 23346194
[TBL] [Abstract][Full Text] [Related]
2. Cimicifuga racemosa dried ethanolic extract in menopausal disorders: a double-blind placebo-controlled clinical trial.
Frei-Kleiner S; Schaffner W; Rahlfs VW; Bodmer Ch; Birkhäuser M
Maturitas; 2005 Aug; 51(4):397-404. PubMed ID: 16039414
[TBL] [Abstract][Full Text] [Related]
3. The effect of a Cimicifuga racemosa extracts Ze 450 in the treatment of climacteric complaints--an observational study.
Drewe J; Zimmermann C; Zahner C
Phytomedicine; 2013 Jun; 20(8-9):659-66. PubMed ID: 23537746
[TBL] [Abstract][Full Text] [Related]
4. Effect of a combination of isoflavones and Actaea racemosa Linnaeus on climacteric symptoms in healthy symptomatic perimenopausal women: a 12-week randomized, placebo-controlled, double-blind study.
Verhoeven MO; van der Mooren MJ; van de Weijer PH; Verdegem PJ; van der Burgt LM; Kenemans P;
Menopause; 2005; 12(4):412-20. PubMed ID: 16037756
[TBL] [Abstract][Full Text] [Related]
5.
Pkhaladze L; Davidova N; Khomasuridze A; Shengelia R; Panossian AG
Pharmaceuticals (Basel); 2020 May; 13(5):. PubMed ID: 32455817
[No Abstract] [Full Text] [Related]
6. 60 years of Cimicifuga racemosa medicinal products : Clinical research milestones, current study findings and current development.
Henneicke-von Zepelin HH
Wien Med Wochenschr; 2017 May; 167(7-8):147-159. PubMed ID: 28155126
[TBL] [Abstract][Full Text] [Related]
7. Black cohosh and St. John's wort for climacteric complaints: a randomized trial.
Uebelhack R; Blohmer JU; Graubaum HJ; Busch R; Gruenwald J; Wernecke KD
Obstet Gynecol; 2006 Feb; 107(2 Pt 1):247-55. PubMed ID: 16449108
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Cimicifuga racemosa on climacteric complaints: a randomized study versus low-dose transdermal estradiol.
Nappi RE; Malavasi B; Brundu B; Facchinetti F
Gynecol Endocrinol; 2005 Jan; 20(1):30-5. PubMed ID: 15969244
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Cimicifuga racemosa, Hypericum perforatum and Agnus castus in the treatment of climacteric complaints: a systematic review.
Laakmann E; Grajecki D; Doege K; zu Eulenburg C; Buhling KJ
Gynecol Endocrinol; 2012 Sep; 28(9):703-9. PubMed ID: 22385322
[TBL] [Abstract][Full Text] [Related]
10. The non-estrogenic alternative for the treatment of climacteric complaints: Black cohosh (Cimicifuga or Actaea racemosa).
Wuttke W; Jarry H; Haunschild J; Stecher G; Schuh M; Seidlova-Wuttke D
J Steroid Biochem Mol Biol; 2014 Jan; 139():302-10. PubMed ID: 23459142
[TBL] [Abstract][Full Text] [Related]
11. The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers.
Wuttke W; Seidlová-Wuttke D; Gorkow C
Maturitas; 2003 Mar; 44 Suppl 1():S67-77. PubMed ID: 12609561
[TBL] [Abstract][Full Text] [Related]
12. Effects of
Furtado Macruz C; Lima SMRR
J Obstet Gynaecol; 2022 Oct; 42(7):3236-3240. PubMed ID: 35993523
[TBL] [Abstract][Full Text] [Related]
13. First-time proof of endometrial safety of the special black cohosh extract (Actaea or Cimicifuga racemosa extract) CR BNO 1055.
Raus K; Brucker C; Gorkow C; Wuttke W
Menopause; 2006; 13(4):678-91. PubMed ID: 16837890
[TBL] [Abstract][Full Text] [Related]
14. Effect of CIMicifuga racemosa on metaBOLIC parameters in women with menopausal symptoms: a retrospective observational study (CIMBOLIC).
Friederichsen L; Nebel S; Zahner C; Bütikofer L; Stute P
Arch Gynecol Obstet; 2020 Feb; 301(2):517-523. PubMed ID: 31734757
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of human placenta extract in alleviating climacteric symptoms: prospective, randomized, double-blind, placebo-controlled trial.
Lee YK; Chung HH; Kang SB
J Obstet Gynaecol Res; 2009 Dec; 35(6):1096-101. PubMed ID: 20144174
[TBL] [Abstract][Full Text] [Related]
16. [Effectiveness and safety of the treatment of menopausal syndrome with Cimicifuga racemosa dry extract].
Radowicki S; Skórzewska K; Rudnicka E; Szlendak-Sauer K; Wierzba W
Ginekol Pol; 2006 Sep; 77(9):678-83. PubMed ID: 17219796
[TBL] [Abstract][Full Text] [Related]
17. Cimicifuga racemosa isopropanolic extract for menopausal symptoms: an observational prospective case-control study.
Guida M; Raffone A; Travaglino A; Neola D; Reppuccia S; Borgo M; Vitale C; Limone A; D'Alessandro P; Massaro G; Mollo A
Gynecol Endocrinol; 2021 Dec; 37(12):1132-1137. PubMed ID: 34477029
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms.
Osmers R; Friede M; Liske E; Schnitker J; Freudenstein J; Henneicke-von Zepelin HH
Obstet Gynecol; 2005 May; 105(5 Pt 1):1074-83. PubMed ID: 15863547
[TBL] [Abstract][Full Text] [Related]
19. The Effects of a Saffron Extract (affron®) on Menopausal Symptoms in Women during Perimenopause: A Randomised, Double-Blind, Placebo-Controlled Study.
Lopresti AL; Smith SJ
J Menopausal Med; 2021 Aug; 27(2):66-78. PubMed ID: 34463070
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy and safety of Black cohosh (Actaea/Cimicifuga racemosa) in the treatment of vasomotor symptoms--review of clinical trials].
Kanadys WM; Leszczyńska-Gorzelak B; Oleszczuk J
Ginekol Pol; 2008 Apr; 79(4):287-96. PubMed ID: 18592868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
